Suppr超能文献

母亲产前和产后补充维生素 D 对婴幼儿期后代骨量和肌肉力量的影响:一项随机对照试验的随访。

Effect of maternal prenatal and postpartum vitamin D supplementation on offspring bone mass and muscle strength in early childhood: follow-up of a randomized controlled trial.

机构信息

Centre for Global Child Health and SickKids Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.

Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.

出版信息

Am J Clin Nutr. 2022 Mar 4;115(3):770-780. doi: 10.1093/ajcn/nqab396.

Abstract

BACKGROUND

Maternal vitamin D status during pregnancy and lactation is a modifiable factor that may influence offspring musculoskeletal outcomes. However, few randomized trials have tested the effects of prenatal or postpartum vitamin D supplementation on offspring bone and muscle development.

OBJECTIVES

The aim was to examine hypothesized effects of improvements in early-life vitamin D status on childhood musculoskeletal health in Dhaka, Bangladesh.

METHODS

In a previously completed, double-blind, dose-ranging trial, healthy pregnant women (n = 1300) were recruited at 17-24 weeks' gestation and randomly assigned to a prenatal/postpartum regimen of 0/0, 4200/0, 16,800/0, 28,000/0, or 28,000/28,000 IU cholecalciferol (vitamin D3)/wk until 26 wk postpartum. In this new report, we describe additional follow-up at 4 y of age (n = 642) for longer-term outcomes. Bone mineral content (BMC) and areal bone mineral density (aBMD) were measured by DXA. Grip strength was tested using a hand-held dynamometer. The primary comparison was children of women assigned to 28,000 IU/wk prenatally compared with placebo. Differences are expressed as means and 95% CIs.

RESULTS

Total-body-less-head (TBLH) BMC, TBLH aBMD, and grip strength were similar in the combined high-dose prenatal (28,000/0 and 28,000/28,000 IU/wk) compared with placebo groups (mean difference [95% CI] = 0.61 g [-10.90, 12.13], 0.0004 g/cm2 [-0.0089, 0.0097], and 0.02 kg [-0.26, 0.31], respectively). In dose-ranging analyses, TBLH BMC and aBMD, whole-body BMC and aBMD, and grip strength in each of the prenatal vitamin D groups were not significantly different from placebo (P > 0.05 for all comparisons). Only head aBMD was greater in children of women assigned to the 28,000/28,000-IU regimen compared with placebo (mean difference [95% CI] = 0.024 g/cm2 [0.0009, 0.047], P = 0.042); the effect was attenuated upon adjustment for child height, weight, and sex (P = 0.11).

CONCLUSIONS

Maternal prenatal, with or without postpartum, vitamin D supplementation does not improve child BMC, aBMD, or grip strength at 4 y of age. The MDIG trial and present follow-up study were registered prospectively at www.clinicaltrials.gov as NCT01924013 and NCT03537443, respectively.

摘要

背景

孕妇和哺乳期的维生素 D 状况是一个可改变的因素,可能会影响后代的骨骼肌肉发育。然而,很少有随机试验测试过产前或产后补充维生素 D 对后代骨骼和肌肉发育的影响。

目的

旨在检验改善生命早期维生素 D 状态对孟加拉国达卡儿童骨骼肌肉健康的假设影响。

方法

在之前完成的一项双盲、剂量范围试验中,1300 名健康孕妇在妊娠 17-24 周时入组,并随机分配到产前/产后的方案中,分别为 0/0、4200/0、16800/0、28000/0 或 28000/28000 IU 胆钙化醇(维生素 D3)/wk,直至产后 26 周。在本新报告中,我们描述了 4 岁时(n=642)的额外随访,以了解更长期的结果。通过 DXA 测量骨矿物质含量(BMC)和面积骨矿物质密度(aBMD)。使用手持测力计测试握力。主要比较是接受 28000 IU/周产前维生素 D 治疗的妇女的孩子与安慰剂组的比较。差异表示为平均值和 95%CI。

结果

与安慰剂组相比,全身(头除外)BMC、全身 aBMD 和握力在高剂量产前(28000/0 和 28000/28000 IU/wk)组相似(平均差异[95%CI] = 0.61g[-10.90, 12.13],0.0004g/cm2[-0.0089, 0.0097],0.02kg[-0.26, 0.31])。在剂量范围分析中,每个产前维生素 D 组的全身 BMC 和 aBMD、全身 BMC 和 aBMD 以及握力与安慰剂相比均无显著差异(所有比较的 P>0.05)。只有接受 28000/28000 IU 方案治疗的妇女的孩子的头部 aBMD 较高(平均差异[95%CI] = 0.024g/cm2[0.0009, 0.047],P=0.042);在调整儿童身高、体重和性别后,这种影响减弱(P=0.11)。

结论

孕妇产前、产后补充维生素 D 并不能改善儿童在 4 岁时的 BMC、aBMD 或握力。MDIG 试验和本随访研究分别在 www.clinicaltrials.gov 上进行了前瞻性注册,注册号分别为 NCT01924013 和 NCT03537443。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76bf/8895216/6cfdfd90c105/nqab396fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验